Cargando…
The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
BACKGROUND: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by accumulation of extracellular amyloid beta (Aβ) and intracellular neurofibrillary tangles, leading to chronic activation of astrocytes and microglia and persistent neuroinflammation. Aβ-linked activatio...
Autores principales: | Lantz, Megan J., Roberts, Alyssa M., Delgado, Donovan D., Nichols, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225108/ https://www.ncbi.nlm.nih.gov/pubmed/37245024 http://dx.doi.org/10.1186/s12974-023-02807-9 |
Ejemplares similares
-
The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
por: Forest, Kelly H., et al.
Publicado: (2021) -
Gliotoxicity and Glioprotection: the Dual Role of Glial Cells
por: Quincozes-Santos, André, et al.
Publicado: (2021) -
Succinct Amyloid
and Nonamyloid Patterns in Hexapeptides
por: Keresztes, László, et al.
Publicado: (2022) -
Gliotoxicity of the cyanotoxin, β-methyl-amino-(L)-alanine (BMAA)
por: Chiu, Alexander S., et al.
Publicado: (2013) -
Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017)